Literature DB >> 33404992

Skin Penetration Enhancement Strategies Used in the Development of Melanoma Topical Treatments.

Supreeda Tambunlertchai1, Sean M Geary1, Aliasger K Salem2.   

Abstract

Malignant melanoma is an aggressive form of skin cancer for which there is currently no reliable therapy and is considered one of the leading health issues in the USA. At present, surgery is the most effective and acceptable treatment; however, surgical excision can be impractical in certain circumstances. Topical skin delivery of drugs using topical formulations is a potential alternative approach which can have many advantages aside from being a non-invasive delivery route. Nevertheless, the presence of the stratum corneum (SC) limits the penetration of drugs through the skin, lowering their treatment efficacy and raising concerns among physicians and patients as to their effectiveness. Currently, research groups are trying to circumvent the SC barrier by using skin penetration enhancement (SPE) strategies. The SPE strategies investigated include chemical skin penetration enhancers (CPEs), physical skin penetration enhancers (PPEs), nanocarrier systems, and a combination of SPE strategies (cream). Of these, PPEs and cream are the most advanced approaches in terms of preclinical and clinical studies, respectively.

Entities:  

Keywords:  cream formulations; melanoma; skin penetration; topical drug delivery

Mesh:

Substances:

Year:  2021        PMID: 33404992     DOI: 10.1208/s12248-020-00544-y

Source DB:  PubMed          Journal:  AAPS J        ISSN: 1550-7416            Impact factor:   3.603


  87 in total

1.  Systemic administration of a TLR7 ligand leads to transient immune incompetence due to peripheral-blood leukocyte depletion.

Authors:  Matthias Gunzer; Helge Riemann; Yasmin Basoglu; Anja Hillmer; Carsten Weishaupt; Sandra Balkow; Bernd Benninghoff; Beat Ernst; Meike Steinert; Thomas Scholzen; Cord Sunderkötter; Stephan Grabbe
Journal:  Blood       Date:  2005-06-23       Impact factor: 22.113

Review 2.  Resiquimod and other immune response modifiers as vaccine adjuvants.

Authors:  Mark A Tomai; Richard L Miller; Kenneth E Lipson; William C Kieper; Isidro E Zarraga; John P Vasilakos
Journal:  Expert Rev Vaccines       Date:  2007-10       Impact factor: 5.217

3.  Mechanism of percutaneous adsorption. I. Routes of penetration and the influence of solubility.

Authors:  R J Scheuplein
Journal:  J Invest Dermatol       Date:  1965-11       Impact factor: 8.551

4.  Melanoma: Molecular Pathogenesis and Therapeutic Management.

Authors:  Yuxin Liu; M Saeed Sheikh
Journal:  Mol Cell Pharmacol       Date:  2014

Review 5.  Malignant melanoma: prevention, early detection, and treatment in the 21st century.

Authors:  D S Rigel; J A Carucci
Journal:  CA Cancer J Clin       Date:  2000 Jul-Aug       Impact factor: 508.702

6.  Cancer Statistics, 2017.

Authors:  Rebecca L Siegel; Kimberly D Miller; Ahmedin Jemal
Journal:  CA Cancer J Clin       Date:  2017-01-05       Impact factor: 508.702

7.  Type I interferons directly regulate lymphocyte recirculation and cause transient blood lymphopenia.

Authors:  Elisabeth Kamphuis; Tobias Junt; Zoe Waibler; Reinhold Forster; Ulrich Kalinke
Journal:  Blood       Date:  2006-07-25       Impact factor: 22.113

8.  Randomized, single-blind, placebo-controlled study of topical application of the immune response modulator resiquimod in healthy adults.

Authors:  Daniel N Sauder; Michael H Smith; Therese Senta-McMillian; Inmaculada Soria; Tze-Chiang Meng
Journal:  Antimicrob Agents Chemother       Date:  2003-12       Impact factor: 5.191

9.  Transdermal delivery of molecules is limited by full epidermis, not just stratum corneum.

Authors:  Samantha N Andrews; Eunhye Jeong; Mark R Prausnitz
Journal:  Pharm Res       Date:  2012-11-30       Impact factor: 4.200

10.  Melanoma: a global perspective.

Authors:  Raul Ossio; Rodrigo Roldán-Marín; Héctor Martínez-Said; David J Adams; Carla Daniela Robles-Espinoza
Journal:  Nat Rev Cancer       Date:  2017-04-28       Impact factor: 60.716

View more
  2 in total

1.  Enhancement of the Antioxidant and Skin Permeation Properties of Betulin and Its Derivatives.

Authors:  Andrzej Günther; Edyta Makuch; Anna Nowak; Wiktoria Duchnik; Łukasz Kucharski; Robert Pełech; Adam Klimowicz
Journal:  Molecules       Date:  2021-06-05       Impact factor: 4.411

Review 2.  Nanoparticle-Based Drug Delivery Systems for Photodynamic Therapy of Metastatic Melanoma: A Review.

Authors:  Nkune Williams Nkune; Heidi Abrahamse
Journal:  Int J Mol Sci       Date:  2021-11-21       Impact factor: 5.923

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.